Status:
COMPLETED
Assessment of Cognitive and Functional Impairment in Older Patients After ERCP
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Cognitive Impairment
Eligibility:
All Genders
60+ years
Brief Summary
Endoscopic retrograde cholangiopancreatography (ERCP) is an interventional endoscopy procedure utilized in the therapeutic management of pancreatobiliary diseases including gallstones, bile duct stric...
Eligibility Criteria
Inclusion
- Adults aged 60 years or older
- Scheduled to undergo outpatient ERCP and/or EUS at Vanderbilt University Medical Center (VUMC)
Exclusion
- Age \<60 years
- Inpatient status at the time of ERCP/EUS
- Documented history of dementia
- Inability to provide informed consent for study participation, implying baseline neurocognitive dysfunction
- Blind, deaf, or unable to speak English, as these conditions would preclude our ability to perform assessments.
- No access to a telephone to permit pre-procedure and 3 month post-procedure neurocognitive assessment
Key Trial Info
Start Date :
February 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 4 2024
Estimated Enrollment :
215 Patients enrolled
Trial Details
Trial ID
NCT03762954
Start Date
February 8 2019
End Date
April 4 2024
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212